Literature DB >> 31336380

Therapeutic Potential of Wnt-3a in Neurological Recovery after Spinal Cord Injury.

Kai Gao1,2, Tao Zhang1,2, Fang Wang3, Chaoliang Lv4,5.   

Abstract

BACKGROUND: Spinal cord injury (SCI) is a constant challenge in medical research and a global therapeutic problem. Treatment of this condition remains difficult in clinical practice. Hence, prevention, treatment, and rehabilitation of SCI have become imminent tasks in the medical field.
SUMMARY: Recent evidence suggest the important role of Wnt/β-catenin signaling pathway, a canonical Wnt signaling pathway, in neural development, axon guidance, neuropathic pain relief, and neuronal survival. Wnt-3a is regarded as an activator of the canonical Wnt signaling pathway. This activator is expressed in the dorsal midline region and is responsible for spinal cord development. In addition, Wnt-3a plays a regulatory role in autophagy, apoptosis, and regeneration of neurons; neurogenic inflammation; and axon regeneration. Herein, we demonstrated that neuronal autophagy was regulated by Wnt-3a via β-catenin and mammalian target of rapamycin signaling pathways after SCI. Our study also discovered that the Wnt-3a provided a favorable microenvironment for the recovery of nerve function after SCI. Key Messages: This study systematically elaborates the neuroprotective effect of Wnt-3a and its neuroprotection molecular mechanism after SCI. This study provides a new molecular mechanism and research basis for clinical treatment of SCI.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Apoptosis; Autophagy; Axon regeneration; Mammalian target of rapamycin signaling pathway; Neuroprotection; Spinal cord injury; Wnt-3a; Wnt/β-catenin signaling pathway

Mesh:

Year:  2019        PMID: 31336380     DOI: 10.1159/000502004

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  8 in total

Review 1.  On the Common Journey of Neural Cells through Ischemic Brain Injury and Alzheimer's Disease.

Authors:  Jan Kriska; Zuzana Hermanova; Tomas Knotek; Jana Tureckova; Miroslava Anderova
Journal:  Int J Mol Sci       Date:  2021-09-07       Impact factor: 6.208

2.  AAV2-mediated and hypoxia response element-directed expression of bFGF in neural stem cells showed therapeutic effects on spinal cord injury in rats.

Authors:  Sipin Zhu; Yibo Ying; Jiahui Ye; Min Chen; Qiuji Wu; Haicheng Dou; Wenfei Ni; Huazi Xu; Jiake Xu
Journal:  Cell Death Dis       Date:  2021-03-15       Impact factor: 8.469

3.  LncRNA Airsci increases the inflammatory response after spinal cord injury in rats through the nuclear factor kappa B signaling pathway.

Authors:  Tao Zhang; Kang Li; Zi-Lu Zhang; Kai Gao; Chao-Liang Lv
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

4.  Methane Saline Ameliorates Traumatic Brain Injury through Anti-Inflammatory, Antiapoptotic, and Antioxidative Effects by Activating the Wnt Signalling Pathway.

Authors:  Meng Li; Weiman Gao; Le Ji; Jia Li; Wanting Jiang; Wenchen Ji
Journal:  Biomed Res Int       Date:  2020-12-17       Impact factor: 3.411

Review 5.  Living biobank-based cancer organoids: prospects and challenges in cancer research.

Authors:  Haixin Li; Hongkun Liu; Kexin Chen
Journal:  Cancer Biol Med       Date:  2022-07-21       Impact factor: 5.347

6.  Identification of a Novel Axon Regeneration Role for Noncanonical Wnt Signaling in the Adult Retina after Injury.

Authors:  Ganeswara Rao Musada; Tal Carmy-Bennun; Abigail S Hackam
Journal:  eNeuro       Date:  2022-08-11

Review 7.  The PI3K/AKT signalling pathway in inflammation, cell death and glial scar formation after traumatic spinal cord injury: Mechanisms and therapeutic opportunities.

Authors:  Xuegang He; Ying Li; Bo Deng; Aixin Lin; Guangzhi Zhang; Miao Ma; Yonggang Wang; Yong Yang; Xuewen Kang
Journal:  Cell Prolif       Date:  2022-06-26       Impact factor: 8.755

Review 8.  Wnt Signaling Pathways: A Role in Pain Processing.

Authors:  Yiting Tang; Yupeng Chen; Rui Liu; Weidong Li; Baojin Hua; Yanju Bao
Journal:  Neuromolecular Med       Date:  2022-01-24       Impact factor: 4.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.